Ann: Change of Director's Interest Notice and Appendix 3B amendme, page-2

Fact - This Ann is in relation to yet more performance shares being issued.

Fact - There are 12.5m more performance shares approved and waiting to be issued.

Fact - Adrian Griffen's remuneration is comparable to the Prime Minister's salary.

Fact - There is no forecasted revenue and no past revenue to speak of to. To satisfactorily establish appropriate remuneration levels.

Fact - LIT publicly stated that HF was not used within the "Sileach" process. Where the patent application stated that the production of HF in situ is intrinsic to the application.

Fact - LIT had possession of intellectual property relating to Lithium processing. Before "developing" competing processes.

Fact - Legal proceedings to clarify the use of said IP, would be a major burden and significant strain on an already poorly funded and poorly supported micro cap penny stock.

Fact - It is currently unknown how the underwriters intend to generate their own revenue with the stock issued to them, in exchange for their partial support of the recent credit raising.

Fact - The last bench scale experiment using the "Sileach" process was aborted within circa 24hrs. This being well short of the intended and announced period for the trial run.

Fact - Past bench scale experiments using "Sileach" were conducted using a mica input feed. Despite the many claims of being applicable to all silicates including spodumene. No supporting information has been publicly released justifying that claim is commercially viable.

Is anybody else concerned about these facts?

@ProCapitalism ?